These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21673434)

  • 21. In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.
    Pellizzari Tregno F; Sau A; Pezzola S; Geroni C; Lapenta C; Spada M; Filomeni G; Bonanno E; Federici G; Caccuri AM
    Eur J Cancer; 2009 Sep; 45(14):2606-17. PubMed ID: 19665369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells.
    Ascione A; Cianfriglia M; Dupuis ML; Mallano A; Sau A; Pellizzari Tregno F; Pezzola S; Caccuri AM
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):419-24. PubMed ID: 19288261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
    Wei L; Song XR; Wang XW; Li M; Z uo WS
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for osteosarcoma and Ewing's sarcoma.
    Saeter G; Alvegård TA; Elomaa I; Wiebe T; Björk O; Strander H; Solheim OP
    Acta Orthop Scand Suppl; 1997 Feb; 273():120-5. PubMed ID: 9057601
    [No Abstract]   [Full Text] [Related]  

  • 25. Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
    Miyake K; Murakami T; Kiyuna T; Igarashi K; Kawaguchi K; Li Y; Singh AS; Dry SM; Eckardt MA; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Endo I; Eilber FC; Hoffman RM
    J Cell Biochem; 2018 Jan; 119(1):967-972. PubMed ID: 28681998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolution of chemotherapeutic agents for the treatment of pediatric musculoskeletal malignancies.
    Velez-Yanguas MC; Warrier RP
    Orthop Clin North Am; 1996 Jul; 27(3):545-9. PubMed ID: 8649735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol: a promising new anticancer compound.
    Sha HH; Wang Z; Dong SC; Hu TM; Liu SW; Zhang JY; Wu Y; Ma R; Wu JZ; Chen D; Feng JF
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29358310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preoperative adjuvant therapy for primary malignant bone tumors].
    Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alternative chemotherapy of malignant bone neoplasms in children].
    Jurczyk-Procyk S; Perek D
    Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NBDHEX re-sensitizes adriamycin-resistant breast cancer by inhibiting glutathione S-transferase pi.
    Sha H; Zou R; Lu Y; Gan Y; Ma R; Feng J; Chen D
    Cancer Med; 2023 Mar; 12(5):5833-5845. PubMed ID: 36266920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.
    Pasello M; Hattinger CM; Stoico G; Manara MC; Benini S; Geroni C; Mercuri M; Scotlandi K; Picci P; Serra M
    Eur J Cancer; 2005 Sep; 41(14):2184-95. PubMed ID: 16140527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of glutathione-S-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma.
    Seitz G; Bonin M; Fuchs J; Poths S; Ruck P; Warmann SW; Armeanu-Ebinger S
    Int J Oncol; 2010 Feb; 36(2):491-500. PubMed ID: 20043085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotherapy of sarcomas in the adult].
    Rouëssé J; Tubiana-Hulin M
    Bull Cancer; 1988; 75(5):483-92. PubMed ID: 3165036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
    Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
    Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
    Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy of advanced bone and soft tissue sarcoma].
    Yamawaki S; Isu K; Ubayama Y; Yamaguti H; Gotou M
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1757-63. PubMed ID: 6541020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.
    Garofalo C; Capristo M; Manara MC; Mancarella C; Landuzzi L; Belfiore A; Lollini PL; Picci P; Scotlandi K
    PLoS One; 2013; 8(12):e83832. PubMed ID: 24391834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Tanaka K; Yasunaga Y; Sakai A; Ochi M
    J Orthop Res; 2006 Jun; 24(6):1138-44. PubMed ID: 16705696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma.
    Bacci G; Picci P; Mercuri M; Ferrari S; Longhi A; Cesari M; Rosito P; Mancini AF; Barbieri E; Baldini N
    Acta Oncol; 1998; 37(7-8):671-6. PubMed ID: 10050985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.